| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 211996 |
MZ 1 PROteolysis-TArgeting Chimeras 技术 |
452 |
wff |
2023-11-16 |
| 211997 |
dBET6 PROTAC蛋白降解靶向联合体 |
411 |
wff |
2023-11-16 |
| 211998 |
15:0 PC 3355-27-9 1,2-二十五酰基卵磷脂 |
475 |
LYQ |
2023-11-16 |
| 211999 |
ZXH-3-26 PROteolysis-TArgeting Chimeras 技术 |
344 |
wff |
2023-11-16 |
| 212000 |
ARV-825 PROTAC蛋白降解靶向联合体 |
588 |
wff |
2023-11-16 |
| 212001 |
PROTAC ERRα Degrader-3 泛素-蛋白酶体系统靶蛋白 |
417 |
wff |
2023-11-16 |
| 212002 |
13:0 PC 71242-28-9 1,2-二十三烷酰基-sn-甘油-3-磷酸胆碱 |
397 |
LYQ |
2023-11-16 |
| 212003 |
PROTAC AR-V7 degrader-1 蛋白水解靶向嵌合分子 |
328 |
wff |
2023-11-16 |
| 212004 |
cas:6974-32-9 1-乙酰氧基-2,3,5-三苯甲酰氧基-1-β-D-呋喃核糖 |
449 |
zyl |
2023-11-16 |
| 212005 |
PROTAC STING Degrader-1 蛋白水解靶向嵌合体 |
623 |
wff |
2023-11-16 |
| 212006 |
cas:84297-22-3 1-萘基-Β-D-甘露糖苷 1-naphthyl-b-d-mannose的密度 |
405 |
zyl |
2023-11-16 |
| 212007 |
CP-10 PROteolysis-TArgeting Chimeras 技术 |
372 |
wff |
2023-11-16 |
| 212008 |
PROTAC RIPK degrader-6 小分子抑制剂 |
412 |
wff |
2023-11-16 |
| 212009 |
16:0 2-PC 1,3-二棕榈酰rac-甘油-2-磷酸胆碱 1,3-dipalmitoyl-rac-glycero-2-phosphocholine |
361 |
LYQ |
2023-11-16 |
| 212010 |
11:0 PC 27869-47-2 L-α-磷脂酰胆碱 |
388 |
LYQ |
2023-11-16 |
| 212011 |
PCL-PEG-Pemetrexed,聚己内酯-聚乙二醇-培美曲塞 |
375 |
lcy |
2023-11-16 |
| 212012 |
PCL-PEG-Raltitrexed,聚己内酯-聚乙二醇-雷替曲塞 |
435 |
lcy |
2023-11-16 |
| 212013 |
PCL-PEG-Metronidazole,聚己内酯-聚乙二醇-甲硝唑 |
382 |
lcy |
2023-11-16 |
| 212014 |
10:0 PC 3436-44-0 二癸酰基卵磷脂 |
350 |
LYQ |
2023-11-16 |
| 212015 |
PCL-PEG-Ferrocene,聚己内酯-聚乙二醇-二茂铁 |
314 |
lcy |
2023-11-16 |
| 212016 |
09:0 PC 27869-45-0 1,2-二壬酰-Sn-甘油-3-磷酰胆碱 |
505 |
LYQ |
2023-11-16 |
| 212017 |
PCL-PEG-Dopamine,聚己内酯-聚乙二醇-多巴胺 |
344 |
lcy |
2023-11-16 |
| 212018 |
PCL-PEG-R8,聚己内酯-聚乙二醇-R8,纯度≥95%,溶于大部分有机溶剂 |
432 |
lcy |
2023-11-16 |
| 212019 |
Azide-PEG4-Br,CAS1951439-37-4,溴代四聚乙二醇叠氮,分子量326.19 |
356 |
axc |
2023-11-16 |
| 212020 |
PCL-PEG-MMPs,聚己内酯-聚乙二醇-MMPs,溶于大部分有机溶剂 |
347 |
lcy |
2023-11-16 |
| 212021 |
Azide-PEG3-Br,CAS1446282-43-4,溴代三聚乙二醇叠氮,分子量282.14 |
425 |
axc |
2023-11-16 |
| 212022 |
Azide-PEG7-OTs,CAS1418561-41-7,叠氮七聚乙二醇对甲苯磺酸酯,分子量505.58 |
406 |
axc |
2023-11-16 |
| 212023 |
PCL-PEG-WSW,聚己内酯-聚乙二醇-WSW |
440 |
lcy |
2023-11-16 |
| 212024 |
Azide-PEG5-OTs,CAS236754-49-7,叠氮五聚乙二醇对甲苯磺酸酯,分子量: 417.48 |
389 |
axc |
2023-11-16 |
| 212025 |
azido-PEG10-OH,cas:73342-16-2,叠氮-PEG10-羟基,分子量:571.65876 |
379 |
axc |
2023-11-16 |
| 212026 |
PCL-PEG-YIGSR,聚己内酯-聚乙二醇-YIGSR |
361 |
lcy |
2023-11-16 |
| 212027 |
PCL-PEG-CCK8,聚己内酯-聚乙二醇-生物活性CCK8肽 |
374 |
lcy |
2023-11-16 |
| 212028 |
azido-PEG5-OH,cas:86770-68-5,叠氮-PEG5-羟基,分子量:263.29 |
316 |
axc |
2023-11-16 |
| 212029 |
PCL-PEG-Octreotide,聚己内酯-聚乙二醇-奥曲肽,纯度≥95% |
351 |
lcy |
2023-11-16 |
| 212030 |
PCL-PEG-CDDP,聚己内酯-聚乙二醇-顺铂,纯度≥95% |
341 |
lcy |
2023-11-16 |
| 212031 |
PCL-PEG-DOX 聚己内酯-聚乙二醇-阿霉素 |
378 |
lcy |
2023-11-16 |
| 212032 |
PCL-PEG-Dextran,聚己内酯-聚乙二醇-葡聚糖 |
350 |
lcy |
2023-11-16 |
| 212033 |
Azido-PEG2-PFP ester,CAS: 1393330-37-4,叠氮-PEG2-PFP酯,分子量:369.3 |
384 |
axc |
2023-11-16 |
| 212034 |
N3-tetra-EGOPFP 抗体-药物偶联物 |
377 |
wff |
2023-11-16 |
| 212035 |
Azido-PEG8-TFP ester,cas:1818294-49-3,分子量:615.58 |
359 |
axc |
2023-11-16 |
| 212036 |
PY-DS-DMBUT-OPFP 2101206-44-2 |
397 |
wff |
2023-11-16 |
| 212037 |
Phe-Lys(Trt)-PAB 1116085-99-4 |
319 |
wff |
2023-11-16 |
| 212038 |
Fmoc-Val-Cit-PAB 159858-22-7 |
441 |
wff |
2023-11-16 |
| 212039 |
Azido-PEG4-TFP ester,cas:1807505-33-4,分子量:439.36 |
380 |
axc |
2023-11-16 |
| 212040 |
PCL-PEG-ConA,聚己内酯-聚乙二醇-刀豆球蛋白A |
340 |
lcy |
2023-11-16 |